Prognostic value of epidermal growth factor expression in breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 1, 1997, Pages 63-68

  Pirinen, R ^a   Lipponen, P ^a   Aaltomaa, S ^a   Syrjanen K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Breast cancer; Epidermal growth factor; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031060239     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01212617     Document Type: Article

References (28)

1. Antoniotti S, Taverna D, Maggiora P, Sapei ML, Hynes NE, De Bortoli M (1994) Oestrogen and epidermal growth factor down-regulate erB-2 oncogene protein expression in breast cancer cells by different mechanisms. Br J Cancer 70: 1095-1101
2. Armstrong DK, Kaufmann SH, Ottaviano YL, Furga Y, Buckley JA, Isaacs JT (1994) Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54:5280-5283
3. Battaglia F, Scambia G, Rossi S, Panici PB, Bellantone R, Polizzi G, Querzoli P, Negrini R, Iacobelli S, Crucitti F, Mancuso S (1988) Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol 11:1685-1690
4. Bhatavdekar JM, Patel DD, Karelia NH, Ghosh N, Shah NG, Balar DB, Trivedi SN (1994) Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study. Breast Cancer Res Treat 30:293-297
5. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377
6. Castellani R, Visscher DW, Wykes S, Sarkar FH, Crissman JD (1994) Interaction of transforming growth factor alpha and epidermal growth factor receptor in breast carcinoma. Cancer 2:344-349
7. Cox DR (1972) Regression models and life tables with discussion. J R Statist Soc[B] 34:187-220
8. Dickson RB, Salomon DS, Lippman ME (1991) Tyrosine kinase receptor nuclear protooncogene interactions in breast cancer. Kluwer Academic, Boston
9. Freiss G, Vignon F (1994) Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells. Mol Endocrinol 10:1389-1396
10. Haapasalo H, Pesonen E (1989) Volume corrected mitolic Index (M/V-index) The standard of mitotic activity in neoplasms. Pathol Res Pract 185:551-554
11. Hofland LJ, Van Den Burg B, Eijck CHJ van, Sprij DM, Koetsveld PM, Lamberts SWJ (1995) Role of tumor derived fibroblasts in the growth of primary cultures of human breast-cancer cells: effect of epidermal growth factor and the somatostatin analogue octreotide. Int J Cancer 60:93-99
12. Kirk J, Carmichael J, Stratford IJ, Harris AL (1994) Selective toxicity of TGF-alpha-PE40 to EGFR positive cell lines: selective protection of low EGFR-expressing cell lines by EGF. Br J Cancer 69:988-994
13. Klijn JGM, Berns PMJJ, Schmitz PJM, Foekens JA (1992) The clinical signification of epidermal growth factor receptor (EGFR) in breast cancer. A review on 5252 patients. Endocrine Rev 1:3-17
14. LeMaistre CF, Meneghetti C, Howes L, Osborne CK (1994) Targeting the EGF receptor in breast cancer treatment. Breast Cancer Res Treat 32:97-103
15. Mansour EG, Ravdin PM, Dressler L (1994) Prognostic factors in early breast carcinoma. Cancer 1:381-395
16. Martinazzi M, Crivelli F, Zampatti C, Martinazzi S (1993) Relationship between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. Pathologica 85:637-644
17. Normanno N, Ciardiello F, Brandt R, Salomon DS (1994) Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 29:11-27
18. O'Sullivan C, Lewis CE, Harris AL, McGree J (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342: 148-149
19. Pirinen R, Lipponen P, Syrjänen K (1995) Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors. Anticancer Res 15: 2835-2840
20. Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK (1992) Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. Cancer Res 52:3636-3641
21. Taverna D, Antoniotti S, Maggiora P, Dati C, DeBortoli M, Hynes NE (1994) erB-2 expression in estrogen-receptor-positive breast tumor cells is regulated by growth-modulatory reagents. Int J Cancer 56:522-528
22. Van Agthoven T, Timmermans M, Foekens JA, Dorssers LCJ, Henzen-Logmans SC (1994) Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal benign, and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 6:1238-1246
23. Veber N, Prevost G, Planchon P, Starzec A (1994) Evidence for growth effect of epidermal growth factor on MDA-MB-231 breast cancer cells. Eur J Cancer 9:1352-1359
24. Wellstein A (1994) Growth factor targeted and conventional therapy of breast cancer. Breast Cancer Res Treat 31:141-152
25. WHO (1981) Histological typing of breast tumors. International Histological classification of tumors, 2. World Health Organisation, Geneva
26. Wollman R, Yahalom J, Maxy R, Pinto J, Fuks Z (1994) Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int J Radiation Oncol Biol Phys 30:91-98
27. Yang J, Popnikolov NK, Sakthivel R, Nandi S (1994) Human breast cancers respond to growth factors in vivo but not in vitro. Cancer Lett 85:13-21
28. Yoshihisa U, Enokizono N, Sagara Y, Kuriwasi K, Takasaki T, Yoshida A, Yoshida H (1992) Immunohistochemical studies on oncogene products (EGF-R, c-erB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status. Virchows Arch [A] 420: 345-351